Back
First Citizens BancShares Vs. Intra-Cellular Therapies Industry Stock Comparison
Sell
50
FCNCA
First Citizens BancShares
Last Price:
1,845.73
Seasonality Move:
6.82%
Sell
14
ITCI
Intra-Cellular Therapies
Last Price:
73.33
Seasonality Move:
39.33%
Sell
50
First Citizens BancShares (FCNCA)
is a Sell
Is First Citizens BancShares a Buy, Sell or Hold?
- The current First Citizens BancShares [FCNCA] share price is $1,877.50. The Score for FCNCA is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- FCNCA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
14
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $73.21. The Score for ITCI is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
FCNCA Stock Price Chart
What is First Citizens BancShares's stock price today?
-
The First Citizens BancShares share price today is $1,877.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FCNCA is experiencing slight buying pressure.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $73.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.
FCNCA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -16.54 | Sell |
| Relative Strength Index (14 RSI): | 45.81 | Sell |
| Chaikin Money Flow: | 39791 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1858.34 - 1987.84) | Sell |
| Bollinger Bands (100): | (1695.06 - 1968.62) | Buy |
ITCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 42.52 | Sell |
| Chaikin Money Flow: | -234523 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.04 - 75.68) | Sell |
| Bollinger Bands (100): | (68.39 - 76.99) | Buy |
FCNCA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1905.64 | Sell |
| 20-day SMA: | 1909.01 | Sell |
| 50-day SMA: | 1950.42 | Sell |
| 200-day SMA: | 1678.17 | Buy |
| 8-day EMA: | 1888.63 | Sell |
| 20-day EMA: | 1906.73 | Sell |
| 50-day EMA: | 1900.61 | Sell |
| 200-day EMA: | 1703.24 | Buy |
ITCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.4 | Sell |
| 20-day SMA: | 74.45 | Sell |
| 50-day SMA: | 75.51 | Sell |
| 200-day SMA: | 70.84 | Buy |
| 8-day EMA: | 74.91 | Sell |
| 20-day EMA: | 74.89 | Sell |
| 50-day EMA: | 74.57 | Sell |
| 200-day EMA: | 70.13 | Buy |
First Citizens BancShares Earnings Growth & FCNCA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $1.39 per share, an increase this year of $21.04 per share, and a decrease next year of $2.78 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.23 per share, an increase this year of $0.97 per share, and an increase next year of $1.07 per share.
First Citizens BancShares Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Intra-Cellular Therapies Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||